Paxman AB (publ) uploaded a News Release
November 9, 2023
PAXMAN Announces US Centers for Medicare and Medicaid Services (CMS) Continues to Support Scalp Cooling, but Reduces Reimbursement Level for 2024
CMS OPPS Final Rule for 2024: CMS continues to support scalp cooling but reduces reimbursement levels from $1,850.50 to $1,250.50 for 2024 under the Hospital Outpatient Prospective Payment System (OPPS) and ASC Payment System.
Importance of CPT Code 0662T: Continued support for the 0662T CPT code allows practitioners to bill for scalp cooling services, ensuring patient access under Medicare.
2021 Data Used for Decision: The reimbursement level reduction was based on data from 2021, the first year of CPT code use for scalp cooling. Less than 5% of providers submitted claims in 2022, highlighting the need for a larger dataset for more accurate reimbursement adjustments in 2025.
Paxman and Dignitana Appeal: Paxman and Dignitana collaborated to appeal the 2024 reimbursement reduction, arguing that the current data is insufficient for a reduction decision.
Positive Trends in Claims Submission: Strong adoption of scalp cooling services among US cancer centers, with 71% of claims submitted in 2022 and 2023 resulting in positive coverage from commercial payers.
Commercial Payers: Payment for code 0662T ranges from $928 to $4,857 per patient, with additional reimbursements under code 0663T ranging from $78 to $1,200 per treatment.
Medicare Patients: Currently, fewer than 15% of scalp cooling patients are Medicare-eligible, as most are under 65.